Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1380 studies found for:    "Kidney cancer"
Show Display Options
Rank Status Study
1 Completed Follow-Up Study of Kidney Cancer Patients
Conditions: Kidney Cancer;   Renal Cell Cancer
2 Not yet recruiting Isoquercetin as an Adjunct Therapy in Patients With Kidney Cancer Receiving First-line Sunitinib: a Phase I/II Trial
Conditions: Renal Cell Carcinoma;   Kidney Cancer
Interventions: Drug: Sunitinib;   Drug: Isoquercetin;   Drug: Placebo
3 Terminated Interleukin-2 in Metastatic Kidney Cancer
Conditions: Renal Cell Cancer Metastatic;   Kidney Cancer Metastatic
Intervention: Drug: Interleukin-2
4 Unknown  Treatment of Patients With Advanced Renal Cancer With a Radio-labeled Antibody, Yttrium-90 Conjugated Chimeric G250
Conditions: Renal Cell Carcinoma;   Kidney Neoplasm;   Renal Cancer;   Kidney Cancer
Intervention: Drug: Yttrium-90 conjugated chimeric G250 (90Y-cG250)
5 Active, not recruiting Immunotherapy Study for Metastatic Renal Cell Cancer
Conditions: Metastatic Renal Cell Carcinoma;   Metastatic Clear-cell Renal Cancer;   Recurrent Renal Cell Carcinoma;   Refractory Renal Cell Carcinoma;   Metastatic Kidney Cancer
Intervention: Biological: HyperAcute®-Renal (HAR) Immunotherapy
6 Terminated Sorafenib in Treating Patients With Locally Advanced or Metastatic Kidney Cancer
Conditions: Hereditary Clear Cell Renal Cell Carcinoma;   Kidney Cancer
Interventions: Drug: sorafenib tosylate;   Procedure: diffusion-weighted magnetic resonance imaging
7 Recruiting Genetic Analysis of Birt Hogg-Dube Syndrome and Characterization of Predisposition to Kidney Cancer
Conditions: Kidney Neoplasms;   Kidney Cancer;   Pneumothorax;   FLCN Protien, Human
8 Terminated Clinical Trial Studying a Personalized Cancer Vaccine in Patients With Non-metastatic Kidney Cancer
Conditions: Kidney Cancer;   Renal Cell Carcinoma
Intervention: Biological: HSPPC-96
9 Completed
Has Results
Sunitinib Malate in Patients With Non-Clear Cell Renal Cell Cancer
Conditions: Renal Cell Cancer;   Kidney Cancer
Intervention: Drug: Sunitinib Malate
10 Completed
Has Results
Pre-surgical Detection of Clear Cell Renal Cell Carcinoma (ccRCC) Using Radiolabeled G250-Antibody
Conditions: Renal Cell Carcinoma;   Kidney Cancer
Interventions: Drug: 124-Iodine-cG250 (124I-cG250);   Procedure: CT
11 Completed Capecitabine, Gemcitabine, and Bevacizumab in Combination for Patients With Sarcomatoid Renal Cell Carcinoma
Conditions: Renal Cell Carcinoma;   Kidney Cancer
Interventions: Drug: Capecitabine;   Drug: Gemcitabine;   Drug: Bevacizumab
12 Completed
Has Results
High-dose Bevacizumab in Advanced Renal Carcinoma Patients
Conditions: Renal Cancer;   Kidney Cancer
Intervention: Drug: Bevacizumab
13 Completed
Has Results
Zoledronate With Atorvastatin in Renal Cell Carcinoma
Conditions: Kidney Cancer;   Renal Cell Carcinoma
Interventions: Drug: Zoledronate;   Drug: Atorvastatin
14 Completed Case-Control Study of Renal Cell Cancer Among Caucasions and African Americans in the United States
Conditions: Kidney Cancer;   Renal Cell Carcinoma
15 Completed AMG 172 First in Human Study in Patients With Kidney Cancer
Conditions: Renal Cell Adenocarcinoma;   Clear Cell Renal Carcinoma;   Clear Cell Renal Cell Carcinoma;   Renal Cell Carcinoma
Intervention: Drug: AMG 172
16 Completed A Phase I Study of Bevacizumab and Sunitinib in Metastatic Renal Cell Carcinoma Patients
Conditions: Metastatic Renal Cell Carcinoma;   Kidney Cancer
Intervention: Drug: Bevacizumab and Sunitinib
17 Terminated Phase 1/2 Study of Metastatic Renal Cancer Using T-Cells Transduced With a T-Cell Receptor Which Recognizes TRAIL Bound to the DR4 Receptor
Conditions: Renal Cancer;   Kidney Cancer
Interventions: Genetic: 2G-1 TCR Retroviral Vector-Transduced lyn;   Drug: Aldesleukin;   Drug: Cyclophosphamide;   Drug: Fludarabine;   Drug: (PG13-A(F/K-F-SGSG-T2a-B (opt) (2G-1 TCR) retroviral vector-transduced lymphocyte
18 Completed
Has Results
Neoadjuvant Clinical Trial to Evaluate the Efficacy of Bevacizumab for Renal Cell Carcinoma
Conditions: Renal Cell Carcinoma;   Kidney Cancer
Intervention: Drug: Bevacizumab
19 Completed Biomarkers in Patients With Kidney Cancer or Cancer of the Urothelium and in Healthy Participants
Conditions: Bladder Cancer;   Kidney Cancer;   Transitional Cell Cancer of the Renal Pelvis and Ureter;   Urethral Cancer
Interventions: Other: immunologic technique;   Other: laboratory biomarker analysis;   Other: mass spectrometry
20 Terminated Serum CA9 Level as Biological Marker of the Treatment Response in Metastatic Renal Cell Cancer
Conditions: Metastatic Kidney Cancer;   Metastatic Renal Cell Carcinoma
Intervention: Other: Serum and urinary CA9 level

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years